| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3229801
Max Phase: Preclinical
Molecular Formula: C18H29N3O5
Molecular Weight: 367.45
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCCCCCN(C[C@H]1O[C@@H](n2cc(C)c(=O)[nH]c2=O)C[C@@H]1O)C(C)=O
Standard InChI: InChI=1S/C18H29N3O5/c1-4-5-6-7-8-20(13(3)22)11-15-14(23)9-16(26-15)21-10-12(2)17(24)19-18(21)25/h10,14-16,23H,4-9,11H2,1-3H3,(H,19,24,25)/t14-,15+,16+/m0/s1
Standard InChI Key: FYHOASCCGOQVDZ-ARFHVFGLSA-N
Associated Targets(non-human)
Thymidine kinase, cytosolic 80 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 367.45 | Molecular Weight (Monoisotopic): 367.2107 | AlogP: 0.92 | #Rotatable Bonds: 8 |
| Polar Surface Area: 104.63 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 9.96 | CX Basic pKa: | CX LogP: 1.03 | CX LogD: 1.03 |
| Aromatic Rings: 1 | Heavy Atoms: 26 | QED Weighted: 0.67 | Np Likeness Score: 0.19 |
References
| 1. Hampton A, Kappler F, Chawla RR.. (1979) Design of species- or isozyme-specific enzyme inhibitors. 1. Effect of thymidine substituents on affinity for the thymidine site of hamster cytoplasmic thymidine kinase., 22 (6): [PMID:458818] [10.1021/jm00192a005] |
Source
Source(1):